Skip to main content
Clinical Trials/JPRN-jRCTs072180005
JPRN-jRCTs072180005
Completed
Phase 2

Clinical research for efficacy and safety of hand-finger rehabilitation robot SMOVE in the goods operation training for the patients with upper limb paresis after recovery stage stroke patients: A pilot study under single center, open-label, randomized, standard therapy controlled trial. - SMOVE pilot study_02

Kagiyama Tomoko0 sites16 target enrollmentOctober 25, 2018

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Kagiyama Tomoko
Enrollment
16
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

o significant difference in recovery of affected hand / upper limb function due to the difference in intervention between the two groups was revealed. No serious side effects due to SMOVE or malfunction of SMOVE during the intervention were observed.

Registry
who.int
Start Date
October 25, 2018
End Date
April 28, 2020
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kagiyama Tomoko

Eligibility Criteria

Inclusion Criteria

  • Age Between 20 y.o. and 85 y.o.
  • in convalescent stage (15 days to 42 days after onset)
  • with cerebral stroke (cerebral infarction or hemorrhage)
  • being treated with rehabilitation therapy in convalescent stage rehabilitation beds.
  • with hand/finger Brunnstrom stage III to IV

Exclusion Criteria

  • with subarachnoid hemorrhage
  • having upper limb paresis caused not by cerebral stroke.
  • with severe hepatic / renal /cardiac / pulmonary failure
  • with malignant tumor not completely cured
  • whose skin condition is not suitable for electrodes placement, or device putting on their hands.
  • with severe spasticity ( upper than MAS 3\)
  • who are treated with type A botulinus toxin or ITB therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials